CFIA Important Update – DIA Declaration

This document was originally circulated by the CFIA on August 28th, 2025. We are sharing the full text here for reference.  Update on Oyster Diseases (MSX and Dermo) MSX/Dermo mise-à-jour pour l’Est du Canada MSX/Dermo Eastern Canada Check-In Thursday August 28, 2025, meeting/ Rencontre du 28 août, 2025   Key Message from Mireille Chiasson (CFIA…

Read More

GenomeAtlantic Impacts At a Glance: The Oyster MSX Issue

This article was originally published by GenomeAtlantic in July, 2025. We are sharing the full text here for reference. All rights remain with the original publisher.  Opening message from Steve Armstrong, our President & CEO, on how genomics is helping turn the tide on oyster disease.  Fighting Back with Disease-Resistant Oyster Seed  When MSX was…

Read More

Detection of Dermo in oysters in Prince Edward Island

The Canadian Food Inspection Agency (CFIA) has confirmed the presence of the aquatic animal disease Dermo (also known as Perkinsosis) in oyster samples collected in Egmont Bay, Prince Edward Island (PEI). Dermo does not pose a risk to human health or food safety, but it can cause increased oyster mortality and decreased growth rates. This…

Read More

Detections of MSX and Dermo in oysters in Quebec

Statement The Canadian Food Inspection Agency (CFIA) has confirmed the presence of the aquatic animal diseases multinucleate sphere unknown (MSX) and Dermo (also known as Perkinsosis) in oyster samples collected in Chaleur Bay, Québec. MSX and Dermo do not pose risks to human health or food safety, but they can cause increased oyster mortality and…

Read More

$3.1M announced to develop MSX-resistant oyster seed

This article was originally published by Genome Atlantic on June 26, 2025. We are sharing the full text here for reference. All rights remain with the original publisher.  FOR IMMEDIATE RELEASE – June 26, 2025 Halifax, NS – MSX is a deadly oyster disease – harmless to humans but fatal to oysters. In Canada, it…

Read More